Malignant Germ Cell Tumor — Trials

Malignant Germ Cell Tumor — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 44
Recruiting: 22
Ph III recruiting: 2
Growth YoY: —
Industry share: 2%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03067181	Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors	recruiting	Phase 3	1,780	Children's Oncology GroupNETWORK	9	Aug 25, 2026	clinicaltrials
NCT02375204	Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors	active not recruiting	Phase 3	420	Alliance for Clinical Trials in OncologyOTHER	12	Jun 16, 2026